Stay updated on AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Sign up to get notified when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.

Latest updates to the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a maintenance/version update to the ClinicalTrials.gov record.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page’s footer/site revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedThe site revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check92 days agoChange DetectedSite revision label updated to v3.4.3 (replacing v3.4.2).SummaryDifference0.1%

- Check114 days agoChange DetectedNew revision label v3.4.2 is displayed, replacing the previous v3.4.1. This appears to be a minor internal update with no visible changes to the study details, eligibility criteria, or other user-facing content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.